Full CoverageTop news
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim ...
Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
By Michael Nedelman, Amanda Sealy & Maggie Fox
Johnson & Johnson single-shot vaccine 85% effective against severe COVID-19 disease
By Sony Salzman
Posts on X
Formerly Twitter
Tedros Adhanom Ghebreyesus
DrTedros
Vaccines are among the most powerful inventions in history, making once-feared diseases preventable.
With continued research, investment and collaboration, we can save millions more lives today and in the next 50 years. #HumanlyPossible
#WorldImmunizationWeek pic.twitter.com/HqBG6ABYuf
Posted on X
Department of Health and Social Care
DHSCgovuk
Book your spring COVID-19 vaccine online or via the NHS App if you are eligible.
You don't need to wait to be invited.
Find out more and book now: nhs.uk/book-vaccine
#WorldImmunisationWeek pic.twitter.com/U6qFADKI2A
Posted on X
NCDC
NCDCgov
The #COVID19 pandemic caused a global and national decline in immunisation coverage.
While more than 4 million more children were vaccinated globally in 2022 compared to 2021, there were still 20 million children who missed out on one or more of their vaccines.… pic.twitter.com/V7gZYr7XNz
Posted on X
Sputnik V
sputnikvaccine
Scientific American: “Vaccination dramatically lowers #longCOVID risk. Several new studies reveal that getting multiple COVID vaccine doses provides strong protection against lingering symptoms.”👇
www.scientificamerican.com/article/vaccination-dramatically-lowers-long-covid-risk/
Posted on X
